NSE › Healthcare

Granules India Limited (GRANULES)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹843.20+2.25%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹1,471 cr
Revenue YoY
+22.8%
Net profit
₹202 cr
Profit YoY
+32.6%
EPS
₹7.73
EPS estimate
₹6.70
Net margin
13.7%

EPS came in at 7.73 against a street estimate of 6.70 — a beat of 15.4%.

Key statistics

Market cap
₹20,515 cr
P/E
30.7
Forward P/E
21.7
P/B
4.02
Book value
₹205.21
EPS (TTM)
₹26.97
52-week high
₹910.00
52-week low
₹431.70
50-day MA
₹813.27
200-day MA
₹657.60
Beta
0.06

Analyst view

with an average price target of ₹919.12.

Shareholding

Promoters
39.31%
Institutions
20.04%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Granules India Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.